Natural history of reflux esophagitis: What is the risk of progression and does it matter clinically?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 12, 2002, Pages 1247-1249

  Talley, Nicholas J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER RISK; DIETARY INTAKE; DISEASE CLASSIFICATION; DISEASE COURSE; EDITORIAL; ENDOSCOPY; EPIDEMIOLOGICAL DATA; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HEREDITY; HUMAN; LIFESTYLE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RISK ASSESSMENT; RISK FACTOR;

EID: 0036435793     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02854.x     Document Type: Editorial

References (26)

1. Locke GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population based study in Olmsted County. Gastroenterology 1997; 112: 1448-56.
2. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastrooesophageal reflux and dyspepsia: A population-based study. NZ J. Med. 2000; 113: 178-81.
3. McDougal NI, Johnson BT, Kee F et al. Natural history of reflux oesophagitis: A 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-6.
4. Nandurkar S, Talley NJ. Epidemiology and natural history of reflux disease. Bailliere's Best Pract. Res. Clin. Gastroenterol. 2000; 14: 743-57.
5. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for adenocarcinoma. N. Engl. J. Med. 1999; 340: 825-31.
6. Ye W, Chow WH, Lagergren J, Yin L, Nyren O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001; 121: 1286-93.
7. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Risk factors for erosive reflux esophagitis: A case-control study. Am. J. Gastroenterol. 2001; 96: 41-6.
8. Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux oesophagitis in the elderly. J. Gastroenterol. Hepatol. 2001; 16: 132-6.
9. Kang JY, Ho KY. Different prevalences of reflux oesophagitis and hiatus hernia among dyspeptic patients in England and Singapore. Eur J. Gastroenterol. Hepatol. 1999; 11: 845-50.
10. Cameron AJ, Lagergren J, Henriksson BS, Nyren O, Locke GR, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002; 122: 55-9.
11. Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastrooesophageal reflux disease in Asia. J. Gastroenterol. Hepatol. 2000; 15: 230-8.
12. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig. Dis. Sci. 2001; 46: 2176-23.
13. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-33.
14. Largergren J, Bergstrom R, Nyren O. No relation between body mass and gastroesophageal reflux symptoms in a Swedish population-based study. Gut 2000; 47: 26-9.
15. Hamada H, Haruma K, Mihara M et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis. Aliment. Pharmacol. Ther. 2000; 14: 729-35.
16. Blaser MJ. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease. J. Infect. Dis. 1999; 179: 1523-30.
17. Dent J, Fendrick AM, Fennerty MB et al. An evidence based appraisal of reflux disease - The Genval Workshop report. Gut 1999; 44 (Suppl. 2): S1-S16.
18. Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients wilth low-grade reflux esophagitis. J. Gastroenterol. Hepatol. 2002; 17: 949-54.
19. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural history of gastroesophageal reflux disease: 17-22 Year follow-up of 60 patients. Am. J. Gastroenterol. 1997; 92: 37-41.
20. McDougal NI, Johnston BT, Collins JSA et al. Disease progression in gastro-oesophageal reflux disease as determined by repeated oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. Eur. J. Gastroenterol. Hepatol. 1997; 9: 1161-7.
21. Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
22. Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ. 1991; 302: 749-52.
23. Pace F, Santalucia F, Bianchi Porro G. Natural history of gastrooesophageal reflux disease without oesophagitis. Gut 1991; 32: 845-8.
24. Van Herwaarden MA, Samsom A, Smout AJPM. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology 2000; 119: 1439-46.
25. Nanadurkar S, Talley NJ. Barrett's esophagus; the long and the short of it. Am. J. Gastroenterol. 1999; 90: 30-40.
26. Cameron AJ, Arora AS. Barrett's esophagus and reflux esophagitis: Is there a missing link? Am. J. Gastroenterol. 2002; 97: 273-8.